ABLIVA AB (NEVPF)
(Delayed Data from OTC)
$0.01 USD
0.00 (0.00%)
Updated May 20, 2024 09:31 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Abliva AB falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 8 | 14 | 7 | 8 |
Income After Depreciation & Amortization | -9 | -8 | -14 | -7 | -8 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -9 | -8 | -14 | -7 | -8 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -8 | -14 | -7 | -8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -8 | -14 | -7 | -8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -8 | -14 | -6 | -8 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -9 | -8 | -14 | -7 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1,056.30 | 739.49 | 370.17 | NA | 171.10 |
Diluted EPS Before Non-Recurring Items | -0.01 | -0.01 | -0.04 | NA | -0.05 |
Diluted Net EPS (GAAP) | -0.01 | -0.01 | -0.04 | -0.03 | -0.05 |
Fiscal Year end for Abliva AB falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | -0.03 | 0.08 | 0.01 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Gross Profit | -0.03 | 0.08 | 0.01 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 2.38 | 1.83 | 2.50 | 3.05 | 2.02 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.41 | -1.75 | -2.49 | -3.05 | -2.02 |
Non-Operating Income | 0.00 | 0.00 | 0.08 | 0.00 | 0.01 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.41 | -1.75 | -2.41 | -3.05 | -2.02 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.41 | -1.75 | -2.41 | -3.05 | -2.02 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.41 | -1.75 | -2.40 | -3.05 | -2.02 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1,259.42 | 1,056.30 | 1,056.30 | 1,056.30 | 1,056.30 |
Diluted EPS Before Non-Recurring Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Diluted Net EPS (GAAP) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |